Metraipolis › archive › dc_ef5b49b96a2e

The Emerging Role of Oncolytic Virotherapy in Glioblastoma Management — Europe PMC PMID:41228258

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41228258
DOI
10.3390/cancers17213465
License (as archived)
solo-consultazione
Archived
2026-11-09T00:36:32.778Z
SHA-256 of the archived text
3f015a0bcf605873918b2c7782eacec4c75cc22330096466d4dddcaa0d078656
Stable URL of this page
https://metraipolis.com/documento/dc_ef5b49b96a2e

How to cite

The Emerging Role of Oncolytic Virotherapy in Glioblastoma Management — Europe PMC PMID:41228258 — Europe PMC (en), https://europepmc.org/article/MED/41228258 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ef5b49b96a2e (Metraipolis archive dc_ef5b49b96a2e, sha256 3f015a0bcf605873918b2c7782eacec4c75cc22330096466d4dddcaa0d078656)
BibTeX
@misc{dcef5b49b96a2e,
  title = {The Emerging Role of Oncolytic Virotherapy in Glioblastoma Management — Europe PMC PMID:41228258},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41228258},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ef5b49b96a2e; sha256 3f015a0bcf605873918b2c7782eacec4c75cc22330096466d4dddcaa0d078656},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41228258. Agents can read the archived copy with the MCP tool read_document.